Evaluation of vindesine in patients with refractory small cell lung cancer
Chang, A.Y.; Witte, R.S.; Tormey, D.C.; Ramirez, G.
Cancer Treatment Reports 68(11): 1407-1408
1984
ISSN/ISBN: 0361-5960 PMID: 6094003 Document Number: 237481
Document emailed within 1 workday
Related Documents
Saito, Y.; Mori, K.; Tominaga, K.; Yokoi, K.; Miyazawa, N. 1991: Five-day continuous infusion of vindesine in the treatment of non-small cell lung cancer--clinical pharmacokinetics of vindesine Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(12): 2129-2132Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Williams, C.J.; Woods, R.; Levi, J.; Page, J. 1988: Chemotherapy for non-small cell lung cancer: a randomized trial of cisplatin/vindesine v no chemotherapy Seminars in Oncology 15(6 Suppl 7: 58-61
Wolf, M.; Hans, K.; Becker, H.; Hässler, R.; von Bültzingslöwen, F.; Goerg, R.; Klaasen, H.A.; Dannhäuser, J.; Holle, R.; Pfab, R. 1994: Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 42-47
Riggi, M.; Cvitkovic, E.; de Cremoux, H.; Ruffie, P.; Monnet, I.; Voisin, S.; Villalobos, W.; Azli, N.; Saltiel, J.C. 1993: Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques) European Journal of Cancer 29a(13): 1914-1915
Thongprasert, S.; Intarapak, S.; Saengsawang, P.; Thaikla, K. 2005: Reliability of the Thai-modified Function Living Index Cancer questionnaire version 2 (T-FLIC 2) for the evaluation of quality of life in non-small cell lung cancer patients Journal of the Medical Association of Thailand 88(12): 1809-1815
Mori, A.; Hirose, T.; Tamura, A.; Kusaka, K.; Matsui, H.; Ohta, K. 2016: Evaluation of the Efficacy and Safety of Platinum Doublet Re-Challenge Chemotherapy in Patients with Recurrent Advanced Non-Small Cell Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(6): 723-726
Wang, X.; Zheng, L.; Ling, L.; Zhang, S.-y.; Xie, Z.-m.; Yu, H.; Su, X.-d.; Wang, J.-y.; Huang, Z.-f.; Yang, M.-t.; Rong, T.-h. 2009: Prospective comparison of CT versus mediastinoscopy in preoperative evaluation of mediastinal lymph node status in patients with non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 31(1): 42-44
Dou, Y.-l.; Qi, X.-l.; Xin, L.; Chen, D.; Zhang, H.-q.; Cui, Q.-c. 2013: Value of detecting epidermal growth factor receptor mutations in non-small cell lung cancer tissue by TaqMan-amplification refractory mutation system Zhonghua Yi Xue Za Zhi 93(10): 768-771
Stamatelopoulos, A.; Kadjianis, F.; Zoganas, L. 2009: Non-small cell lung cancer: pulmonary parenchyma resection in lung-compromised patients Journal of BUON: Official Journal of the Balkan Union of Oncology 14(2): 183-188
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Postmus, P.E.; Schramel, F.M.; Smit, E.F. 1998: Evaluation of new drugs in small cell lung cancer: the activity of gemcitabine Seminars in Oncology 25(4 Suppl 9: 79-82
Sakuma, F.; Kuroda, M.; Takagi, T.; Terashima, K.; Ohishi, A.; Noguchi, S.; Mizuno, A. 1999: Evaluation of chemotherapy with docetaxel and cisplatin in advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 927-932
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Poddubnyĭ, B.K. 1985: Endoscopic diagnosis and evaluation of the effectiveness of combination chemotherapy of small cell lung cancer Voprosy Onkologii 31(10): 18-21
Fargion, S.; Boeri, R.; Cislaghi, V.; Francanzani, A.L.; Piperno, A.; Schmid, C.; Fiorelli, G. 1988: Immunohistochemical evaluation of a panel of monoclonal antibodies for the diagnosis of small cell lung cancer Tumori 74(6): 713-718
Inda, A.M.; Andrini, L.B.; García, M.N.; García, A.L.; Fernández Blanco, A.; Furnus, C.C.; Galletti, S.M.; Prat, G.D.; Errecalde, A.L. 2007: Evaluation of angiogenesis with the expression of VEGF and CD34 in human non-small cell lung cancer Journal of Experimental and Clinical Cancer Research: Cr 26(3): 375-378
Koroleva, E.S.; Losenkov, I.S.; Alifirova, V.M.; Ivanova, S.A.; Goldberg, V.E.; Novikova, N.S. 2014: Diagnosis of paraneoplastic polyneuropathy in patients with breast cancer and small cell lung cancer Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(4): 93-96
Yokoyama, A. 1999: Gemcitabine hydrochloride is a new anti-cancer agent which will be available in the patients with non-small cell lung cancer (NSCLC) in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 908-915
Yang, W.-f.; Tan, G.-z.; Fu, Z.; Yu, J.-m. 2009: Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 31(12): 925-928